MenB vaccine offers men no protection from gonorrhoea, claims major study

A recent study suggests that the Meningitis B vaccine, commonly given to at-risk men, fails to protect against gonorrhoea infections. This finding is significant as it highlights a potential gap in the current vaccination strategy against sexually transmitted infections. With rising cases of gonorrhoea, understanding the limitations of existing vaccines is crucial for developing more effective prevention methods and public health strategies. For the latest details, it's worth checking out the full article on the BBC website.